The global whole slide imaging market size was estimated to be USD 1.68 billion in 2023 and is expected to reach at USD 3.69 billion by 2034 with a CAGR of 7.42% during the forecast period 2024-2034. Rising usage in drug discovery processes, growing technological advancements in whole slide imaging, increasing acceptance of virtual slides over physical slides, surge in prevalence of cancer, rising need for diagnostic laboratories, and growing adoption of advanced technologies in medical imaging technologies are some of the key factors boosting the market growth.
Growing adoption of advanced technologies in medical imaging technologies is predicted to boost the market growth during the forecast period. Whole slide imaging products are employed to offer advanced and improved versions of digital pathology, empowering the diagnosis process and pathological test outcomes. These products find utility in hospitals, pharmaceutical firms, biotechnology companies, pathology laboratories, and testing centers. For instance, in March 2023, Hamamatsu and Siemens Healthineers have unveiled plans to bring the NanoZoomer S360MD slide scanning system to clinical markets. This automated system facilitates the generation, visualization, and organization of digital slides. The NanoZoomer System is specifically designed for pathologists to examine and analyze digital images of surgical pathology slides derived from formalin-fixed paraffin-embedded (FFPE) tissue, catering to in-vitro diagnostic purposes.
By type, hardware was the highest revenue-grossing segment in the global whole slide imaging market in 2023 owing to growing demand for scanners & cameras for imaging technologies, rising product approvals, increasing research & development activities, and surge in launch of advanced product. For instance, in July 2022, Nikon Corporation has introduced LuFact, a novel and highly compact machine vision camera, aimed at expediting the digital transformation within manufacturing facilities. Utilizing Nikon's extensive experience in image processing technology cultivated through years of digital camera advancements, LuFact represents their inaugural foray into machine vision cameras. This thoughtfully engineered camera can be effortlessly integrated into existing machinery, production lines, robotic systems, and a wide array of diverse applications. Additionally, software is predicted to grow at fastest CAGR during the forecast period owing to the rising technological advancements and growing adoption of artificial intelligence in medical imaging technology.
By application, immunohistochemistry (IHC) was the highest revenue-grossing segment in the global whole slide imaging market in 2023 owing to the rising prevalence of chronic diseases, increasing adoption in pathology to observe protein expression in tissue samples, surge in research & development activities in immunohistochemistry, growing demand for immunohistochemistry by biotech companies for early research and late-stage drug development, and rising adoption of artificial intelligence. For instance, in March 2023, Paige has integrated Mindpeak's artificial intelligence (AI) algorithms into its platform for quantifying immunohistochemistry biomarkers. Mindpeak, known for its expertise in image analysis software, has provided AI algorithms tailored for examining immunohistochemistry slides of lung and breast tissue. These algorithms are now accessible on Paige's platform. The technology of immunohistochemistry is currently confined to singular parameter assessments of samples. Additionally, telepathology is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and rising adoption of telepathology to improve diagnostic imaging.
By end-user, diagnostic centres was the highest revenue-grossing segment in the global whole slide imaging market in 2023 owing to the increasing demand for whole slide imaging technology by pathologists, rising demand for accurate diagnosis & imaging, and surge in launch of advanced technology. For instance, in March 2022, Leica Microsystems has introduced Mica, the inaugural Microhub globally. Designed to cater to researchers of all expertise levels in microscopy, the Microhub represents an innovative integrated imaging solution. It harnesses automation tools, machine learning software, and advanced fluorescence unmixing methods to streamline and automate the imaging process, regardless of the user's familiarity with microscopy. Additionally, hospitals is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare infrastructure, growing prevalence of chronic diseases, increasing technological advancements in imaging technologies, and surge in approvals of advanced technologies by regulatory bodies.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing investment by key market players for the development of advanced products, rising initiatives by key market players, increasing research & development activities, and surge in introduction of advanced solutions by market players. For instance, in March 2023, OptraSCAN, a comprehensive digital pathology solution provider, has introduced the OnDemand Digital Pathology solution, which provides a full digital overhaul of pathology labs across North America. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of chronic diseases, increasing demand for precise diagnosis, and growing technological advancements in imaging technology. For instance, in June 2023, The recently launched Evident SLIDEVIEW™ DX VS-M1 whole slide imaging system represents a digital pathology solution designed to provide rapid and efficient diagnosis support for pathologists by producing top-notch slide images swiftly. Constructed with acclaimed optics and cutting-edge digital technology, the SLIDEVIEW DX slide scanner stands as a comprehensive digital pathology solution.
Growing adoption of advanced technologies in medical imaging technologies is predicted to boost the market growth during the forecast period. Whole slide imaging products are employed to offer advanced and improved versions of digital pathology, empowering the diagnosis process and pathological test outcomes. These products find utility in hospitals, pharmaceutical firms, biotechnology companies, pathology laboratories, and testing centers. For instance, in March 2023, Hamamatsu and Siemens Healthineers have unveiled plans to bring the NanoZoomer S360MD slide scanning system to clinical markets. This automated system facilitates the generation, visualization, and organization of digital slides. The NanoZoomer System is specifically designed for pathologists to examine and analyze digital images of surgical pathology slides derived from formalin-fixed paraffin-embedded (FFPE) tissue, catering to in-vitro diagnostic purposes.
By type, hardware was the highest revenue-grossing segment in the global whole slide imaging market in 2023 owing to growing demand for scanners & cameras for imaging technologies, rising product approvals, increasing research & development activities, and surge in launch of advanced product. For instance, in July 2022, Nikon Corporation has introduced LuFact, a novel and highly compact machine vision camera, aimed at expediting the digital transformation within manufacturing facilities. Utilizing Nikon's extensive experience in image processing technology cultivated through years of digital camera advancements, LuFact represents their inaugural foray into machine vision cameras. This thoughtfully engineered camera can be effortlessly integrated into existing machinery, production lines, robotic systems, and a wide array of diverse applications. Additionally, software is predicted to grow at fastest CAGR during the forecast period owing to the rising technological advancements and growing adoption of artificial intelligence in medical imaging technology.
By application, immunohistochemistry (IHC) was the highest revenue-grossing segment in the global whole slide imaging market in 2023 owing to the rising prevalence of chronic diseases, increasing adoption in pathology to observe protein expression in tissue samples, surge in research & development activities in immunohistochemistry, growing demand for immunohistochemistry by biotech companies for early research and late-stage drug development, and rising adoption of artificial intelligence. For instance, in March 2023, Paige has integrated Mindpeak's artificial intelligence (AI) algorithms into its platform for quantifying immunohistochemistry biomarkers. Mindpeak, known for its expertise in image analysis software, has provided AI algorithms tailored for examining immunohistochemistry slides of lung and breast tissue. These algorithms are now accessible on Paige's platform. The technology of immunohistochemistry is currently confined to singular parameter assessments of samples. Additionally, telepathology is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and rising adoption of telepathology to improve diagnostic imaging.
By end-user, diagnostic centres was the highest revenue-grossing segment in the global whole slide imaging market in 2023 owing to the increasing demand for whole slide imaging technology by pathologists, rising demand for accurate diagnosis & imaging, and surge in launch of advanced technology. For instance, in March 2022, Leica Microsystems has introduced Mica, the inaugural Microhub globally. Designed to cater to researchers of all expertise levels in microscopy, the Microhub represents an innovative integrated imaging solution. It harnesses automation tools, machine learning software, and advanced fluorescence unmixing methods to streamline and automate the imaging process, regardless of the user's familiarity with microscopy. Additionally, hospitals is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare infrastructure, growing prevalence of chronic diseases, increasing technological advancements in imaging technologies, and surge in approvals of advanced technologies by regulatory bodies.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing investment by key market players for the development of advanced products, rising initiatives by key market players, increasing research & development activities, and surge in introduction of advanced solutions by market players. For instance, in March 2023, OptraSCAN, a comprehensive digital pathology solution provider, has introduced the OnDemand Digital Pathology solution, which provides a full digital overhaul of pathology labs across North America. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of chronic diseases, increasing demand for precise diagnosis, and growing technological advancements in imaging technology. For instance, in June 2023, The recently launched Evident SLIDEVIEW™ DX VS-M1 whole slide imaging system represents a digital pathology solution designed to provide rapid and efficient diagnosis support for pathologists by producing top-notch slide images swiftly. Constructed with acclaimed optics and cutting-edge digital technology, the SLIDEVIEW DX slide scanner stands as a comprehensive digital pathology solution.
Segmentation: Whole Slide Imaging Market Report 2022 - 2033
Whole Slide Imaging Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Hardware
- Services
- Software
Whole Slide Imaging Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Hematopathology
- Immunohistochemistry
- Telepathology
- Cytopathology
Whole Slide Imaging Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Diagnostic Centres
- Hospitals
- Others
Whole Slide Imaging Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Whole Slide Imaging Market: Type Estimates & Trend Analysis
8. Whole Slide Imaging Market: Application Estimates & Trend Analysis
9. Whole Slide Imaging Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Whole Slide Imaging Market
12. Europe Global Whole Slide Imaging Market
13. Asia Pacific Global Whole Slide Imaging Market
14. Latin America Global Whole Slide Imaging Market
15. MEA Global Whole Slide Imaging Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Nikon Corporation
- 3Dhistech
- Philips Healthcare
- Hamamatsu Photonics KK
- Indica Labs
- Leica Microsystems GmbH
- Visiopharm
- Olympus Corporation
- Mikroscan Technologies Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 1.68 Billion |
| Forecasted Market Value ( USD | $ 3.69 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
